SynthesisPharmacoEconomics2016

Use of Intermediate Endpoints in the Economic Evaluation of New Treatments for Advanced Cancer and Methods Adopted When Suitable Overall Survival Data are Not Available.

Catherine Beauchemin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.